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and cell replacement therapy. For example, 
recent demonstration that hESCs can be 
induced to differentiate and become motor 
neurons (MNs) offers unprecedented 
opportunity for studying MN develop-
ment/function and developing cell-based 
therapies.[2] However, current MN differ-
entiation protocols, based on soluble fac-
tors and small molecules that inhibit and/
or stimulate particular signaling pathways 
in defined culture conditions, not only are 
limited by low differentiation purity and 
yield, but also require prolonged cell cul-
ture that can take several weeks.[3]
Mechanical forces are generated 
and transmitted across multiple scales, 
affecting cell fate during early embryonic 
development.[4] It has been increasingly 
recognized that besides chemical factors, 
biomechanical and topographical cues 
also play critical roles in differentiation 
and self-renewal of hESCs.[5] Thus new 
bioengineering tools and methods that 
leverage the intrinsic mechanosensitivity of hESCs may have 
the potential to improve hESC differentiation protocols.[6]
While static mechanical factors such as substrate stiffness 
have been shown to mediate hESC behavior including their 
differentiation,[5] the effects of dynamic mechanical forces on 
hESCs have not been fully understood or exploited. This is 
due in part to the lack of appropriate techniques for applying 
dynamic forces to multiple cells in a high throughput fashion. 
Techniques such as atomic force microscopy (AFM)[7] and 
optical tweezer, although capable of applying subcellular 
dynamic forces, are limited to single cell analysis and often 
require expensive instrumentation. Magnetic twisting cytom-
etry (MTC),[8] which uses functionalized magnetic microbeads 
attached to cells to apply forces to multiple cells, has been 
employed for microrheology and mechanobiology studies. 
However, solid microbeads are difficult to remove from cells, 
limiting post-MTC downstream assays and longitudinal studies 
that require continuous culture of cells devoid of exogenous 
materials.
Acoustic tweezing cytometry (ATC)[9] is an ultrasound-based 
technique that utilizes ultrasound pulses to actuate encap-
sulated microbubbles (MBs) bound to integrin receptors to 
exert controlled forces to multiple cells simultaneously. MBs 
with stabilizing lipid or polymer shells (radius 1–3 µm) have 
been established as contrast agents for diagnostic ultrasound 
imaging[10] and exploited for drug/gene delivery applica-
tions.[11,12] Functionalization of MBs by decorating their shell 
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Neural Induction
Human embryonic stem cells (hESCs), derived from the inner 
cell mass of pre-implementation embryos, are capable of dif-
ferentiating into all three germ layers.[1] Successful isolation 
and culture of hESCs in vitro have provided new opportuni-
ties for investigating basic stem cell biology and early human 
embryonic development. In particular, directed differentiation 
of hESCs has made it possible to generate specific cell types, 
opening up new frontiers for disease modeling, drug screening, 
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with ligands to target specific cell membrane receptors enables 
ultrasound molecular imaging.[13] These applications exploit 
the robust responses of MBs to ultrasound excitation.[11,14] MBs 
expand and contract, or collapse when subjected to the periodic 
acoustic pressure of an ultrasound field. Volume expansion 
and contraction of MBs can generate microstreaming of sur-
rounding fluid to exert shear stress on nearby cells, allowing 
probing cell deformability[15] and manipulating single cells and 
organisms.[16] In addition, a MB in an ultrasound field is also 
subjected to a net force, that is, the acoustic radiation force, due 
to momentum transfer from an ultrasound field.[17] It is this 
acoustic radiation force that ATC utilizes to displace integrin-
bound MBs without detachment, thereby applying a force/
strain to cells via the MB-integrin-cytoskeleton (CSK) linkage. 
With a broadly applied ultrasound field with controlled param-
eters such as center frequency, acoustic pressure, pulse length, 
and pulse repetition frequency, ATC is capable of applying 
a defined force/strain to a large number of cells simultane-
ously with a subcellular resolution.[9] Since gas filled MBs can 
be readily removed from the cells after ATC without leaving 
behind exogenous materials, and re-applied if needed for addi-
tional treatment, ATC provides an advantageous and biocom-
patible platform for mechanobiology applications.
Indeed, we have shown the utility of ATC for both cel-
lular mechanical property characterization[9,18,19] and genera-
tion of desirable mechanoresponses, including enhancement 
of osteogenic differentiation of mesenchymal stem cells[20] 
and improvement of hESC survival.[21] Particularly, we have 
recently demonstrated[22] that application of integrin-targeted 
cyclic forces to hESCs for 30 min using ATC induced rapid 
down-regulation of E-cadherin as well as up-regulation of 
N-cadherin, Slug and Snail1, markers associated with epithelial-
mesenchymal transition (EMT), suggesting that ATC induced 
exit of pluripotency and initiation of differentiation of hESCs.[23]
Embryonic development involves a highly dynamic process 
with a spatiotemporally changing physical environment. Thus 
it is possible that the dynamic forces applied by ATC could pro-
vide potent mechanical cues to initiate hESC differentiation 
and EMT.[22] Considering the changes in physical environment 
during development occur in the presence of soluble factors, 
this study is therefore motivated to leverage the novel capa-
bility of ATC to exploit the combined effects of integrin-targeted 
cyclic mechanical forces and biochemical factors for neural 
induction of hESCs.
This study utilized ATC to apply targeted mechanical force/
strain to hESCs via functionalized MBs attached to the cells. In 
our experiments, MBs (SIMB4-5, Advanced Microbubble Labo-
ratories, Boulder, CO) were decorated with RGD peptides tar-
geting the αVβ3 integrin receptor of hESCs (Figure 1A,B). An 
ATC setup suitable for high-throughput application was imple-
mented (Figure 1C), where a planar ultrasound transducer 
(center frequency 1 MHz) generated a series ultrasound pulses 
with defined acoustic pressure amplitudes, pulse duration, and 
pulse repetition frequency (Figure 1D). The ultrasound trans-
ducer, controlled by a computer-controlled positioning system, 
was submerged in a water tank to deliver the ultrasound pulses 
to the adherent cells at the Rayleigh distance of the trans-
ducer (55 mm) without direct contact with the cells/medium 
(Figure 1C). The transducer was set at a 45o angle to minimize 
the interferences from direct reflections of ultrasound field and 
to displace the integrin-bound MBs on the surface of cells. As 
shown by real-time video-microscopic recording (Figure 1E; 
Figure S1, Movie S1, Supporting Information), integrin-bound 
MBs were moved by the acoustic radiation force associated with 
the applied ultrasound pulses. Without detachment, the dis-
placed MBs retreated back toward their pre-ultrasound positions 
after each ultrasound pulse (Figure 1E; Movie S1, Supporting 
Information). While the time-dependent MB displacement 
and retraction curves can be used for cellular mechanical 
characterization,[19] displacement of integrin-anchored MBs 
essentially induced distortion or stretching of the cellular 
structure or molecular assemblies within the cells via the MB-
RGD-integrin-CSK linkage, thereby generating a strain to the 
underlining cells. Application of a series of ultrasound pulses 
generated cyclic MB displacement and cyclic strain to cells with 
an amplitude and frequency dependent on parameters such as 
the acoustic pressure and pulse repetition frequency.
To examine how ATC-induced displacement of integrin-
anchored MBs affected hESCs, we measured the 5-pulse accu-
mulative displacement of MBs as the sum of the net peak 
displacement achieved during each of the first five ultrasound 
pulses (3.04 ± 0.47 µm, n = 30) and assessed the ensuing 
change of Oct4 expression in the cells. Comparison of the 
results from the ATC group (+MB+US) and control (−MB−US) 
revealed significant decrease of Oct4 expression in the cells 
treated by ATC (Figure 1F).
Displacement of integrin-bound MBs may infer the 
mechanical strain generated in the cells by ATC applica-
tion. For example, a 5-pulse accumulative MB displacement 
of 3.04 µm, corresponding to an average of displacement of 
0.61 µm per ultrasound pulse, could suggest an overall strain 
of 6% to the cells, assuming an average length of 10 µm for 
the MB-RGD-integrin-CSK linkage. Of course, determina-
tion of the exact strain applied to the cells by ATC requires 
knowledge of the actual geometry and length of the MB-RGD-
integrin-CSK linkage that was affected by ATC, which could 
not be readily obtained. In addition, ATC-induced stretch/
deformation may not be uniformly distributed among the 
molecular assemblies within focal adhesions (FAs) and CSKs, 
making it difficult to determine precisely the strain distribu-
tion at the molecular level. Nevertheless, ATC-mediated dis-
placement of integrin-anchored MBs is expected to generate 
molecular distortion and structural changes within the cells. 
Since force-induced structural change/functional modification 
has been recognized as a key factor in conversion of mechan-
ical forces into biological signals in mechanotransduction,[24] 
application of ATC may lead to functional modification of the 
focal adhesion and CSK proteins to impact hESC self-renewal 
or differentiation.
Therefore, this study was designed to leverage the capability 
of ATC-mediated cyclic forces/strains on hESCs and to investi-
gate the combined action of ATC and NIM for neural induction 
of hESCs, as represented by expression of early neuroectoderm 
markers (Pax6 and Sox1) and formation of neural-like rosettes 
(Figure 1G).
During neural differentiation of hESCs, cells express Pax6 
and Sox1[25] and undergo morphogenetic events characterized 
by formation of radially organized cells described as “neural 
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tube-like rosettes.”[26] Pax6 and Sox1 are early neuroecdoderm 
markers and used to monitor neural induction. Neural rosettes, 
representing a developmental signature of neuroprogenitors 
derived from hESCs in vitro, recapitulate the molecular and 
morphogenetic sequence of events from gastrulation.[27] Cells 
in this stage can differentiate into various region-specific neural 
cell types including MNs in response to appropriate cues.[28]
We therefore conducted experiments to examine whether 
ATC application could regulate Pax6 and Sox1 expression. Our 
results from immunocytochemistry (ICC) analysis show that 
hESCs treated by ATC for 30 min followed by culture in NIM 
(+MB+US+NIM) exhibited decreased Oct4 expression, along 
with increased expression of both Pax6 and Sox1 as early as 
6 h after ATC application (Figure 2A,B). ATC treatment also 
induced loss of cytoplasmic β-catenin, a transcriptional co-
activator for regulation of gene expression.[29] Detailed analysis 
of intracellular fluorescence signals revealed that, compared 
to control cells without ATC treatment (−MB−US+NIM), 
about 50% of ATC-treated cells (+MB+US+NIM) exhibited 
decreased Oct4 along with increased Pax6 and Sox1 at this time 
point (Figure 2C,D). In contrast, no changes were observed 
in cells in the following three control groups: −MB−US+NIM 
(Figure 2A,B), −MB+US+NIM (Figure S2, Supporting Informa-
tion), and +MB−US+NIM (Figure S2, Supporting Information), 
suggesting that NIM alone was insufficient to induce changes 
in transcription factor or neuroectoderm markers at this time 
point. On the other hand, in the absence of NIM, cells treated 
by ATC (+MB+US−NIM) exhibited decreased Oct4 expression, 
as observed previously,[22] but showed no change in Pax6 and 
Sox1 expression (Figure 2E–H). Results of statistical anal-
ysis the four groups with NIM (Figure 2C; Figure S2C, Sup-
porting Information) and two groups without NIM (Figure 2G) 
shown in Table S1, Supporting Information indicate that ATC 
induced statistically significant changes in Pax6 and Sox1 in the 
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Figure 1. Application of acoustic tweezing cytometry (ATC) to hESCs using ultrasound (US) excitation of integrin-anchored microbubbles (MBs) to 
induce hESC neural differentiation. A) A bright field microscopic image showing targeted MBs attached to hESCs in a colony. Inset shows a single 
cell with an attached MB. B) An illustration of an integrin-bound MB via RGD-integrin binding subjected to the directional acoustic radiation force 
of ultrasound (US) pulses, exhibiting translational movement and exerting a defined strain to the cells via the integrin-focal adhesion-cytoskeleton 
linkage. C) Experiment setup for high through-put ATC application. D) US pulses used in ATC application. A total 30 min application of US pulses 
(pulse repetition frequency 1 Hz) was used, with the acoustic pressure increased every 10 min, from 0.035 MPa in the first 10 min, to 0.045 MPa the 
second 10 min, and to 0.055 MPa the last 10 min. E) Example of measured displacement of an integrin-bound MB during application of three US 
pulses. F) Fluorescence intensity of OCT4 expression in hESCs in ATC-group and control group in respectively. A total of 420 cells for the ATC group 
and 307 cells for control were analyzed. Experiments were conducted for at least n = 3. Mann–Whitney test (for non-normal distributed data) was 
used to compare the Oct4 intensity between these two conditions. ****p < 0.0001. G) Experimental protocol for neural induction of hESCs by ATC 
application (30 min) followed by culture in NIM.
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Figure 2. ATC treatment followed by 6-h culture in NIM decreased expression of OCT4, upregulated PAX6 and SOX1. A,B) Representative confocal 
immunocytochemical (ICC) fluorescence images showing protein expression in hESCs with (+MB+US) or without ATC treatment (−MB−US). Scale bar 
50 µm. C) Histograms of fluorescence intensity of OCT4, PAX6, and SOX1 in cells treated by ATC (+MB+US+NIM) and in cells without ATC (−MB−
US+NIM). A total number of 2440 cells (+MB+US+NIM) and 1240 cells (−MB−US+NIM) from six independent experiments were analyzed for OCT4. 
A total number of 1376 cells (+MB+US+NIM) and 429 cells (−MB−US+NIM) from three independent experiments were analyzed for PAX6. A total 
number of 1064 cells (+MB+US+NIM) and 811 cells (−MB−US+NIM) from three independent experiments were analyzed for SOX1. D) Scatter plots 
of PAX6 versus OCT4 and SOX1 versus OCT4 for cells in +MB+US+NIM and −MB−US+NIM group. E,F) Representative ICC images showing that ATC 
(+MB+US) treatment in the absence of NIM decreased OCT4 in some hESCs. No increase in PAX6 or SOX1 was observed in both +MB+US−NIM 
and −MB−US−NIM group. Scale bar 50 µm. G) Histograms of fluorescence intensity for OCT4, PAX6, and SOX1 in +MB+US−NIM and −MB−US−NIM 
group. A total of 1933 cells (+MB+US−NIM) and 2857 cells (−MB−US−NIM) from three independent experiments were analyzed for OCT4. A total of 
586 cells (+MB+US−NIM) and 1292 cells (−MB−US−NIM) from three independent experiments were analyzed for PAX6. A total number of 1347 cells 
(+MB+US−NIM) and 1565 cells (−MB−US−NIM) from three independent experiments were analyzed for SOX1. H) Scatter plots of PAX6 versus OCT4, 
and SOX1 versus OCT4 for +MB+US−NIM and −MB−US−NIM group.
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presence of NIM compared with the controls without ATC. In 
addition, ATC induced no changes in Pax6 and Sox1 in cells 
without NIM.
Although the ICC images show decreases in Oct4 in 
some cells at 6 h after ATC application with culture in NIM 
(Figure 2A,B), comparisons of the mean values reveal no sta-
tistically significant differences in Oct4 signals between the 
ATC group (+MB+US+NIM) and controls without ATC (−MB−
US+NIM, +MB−US+NIM, and –MB+US+NIM) (Figure S2C, 
Table S1, Supporting Information). This is likely due to the het-
erogeneity in the cellular responses, as shown in the distribu-
tion of the Oct4 signals. Even though decreases were detected 
for some cells, the mean value from the overall population did 
not reflect such changes in the subpopulation of cells.
Taken together, our results show that the combined action 
of ATC and NIM induced upregulation of neuroectodermal 
markers Pax6 and Sox1 as early as 6 h. Either NIM (6-h cul-
ture) or ATC treatment (30 min) alone had no effect on either 
Pax6 or Sox1. Even though ATC alone, without NIM, initi-
ated loss of Oct4 in some cells, upregulation of Pax6 and Sox1 
required both ATC and NIM, suggesting an integrated mecha-
nism involving both cyclic force/strain and chemical factors for 
neural induction of hESCs.
The ability of cells to sense and respond to mechanical sig-
nals is critical in development and relies on signaling pathways 
involving cell-ECM and cell-cell interaction. To determine how 
the effects of ATC on hESCs were associated with FAs and 
CSKs, we conducted experiments where cells were pre-treated 
for 30 min by either Blebbistatin (myosin II activity inhibitor), 
or FAK inhibitor, or Y-27632 (RhoA/ROCK signaling inhibitor) 
1 h before ATC application. The cells were cultured in NIM for 
6 h after ATC application. Results from immunocytochemistry 
(ICC) analysis show that the effects of ATC were abrogated 
by these drug treatments using Blebbistatin, FAK inhibitor, 
or Y-27632. No changes in expression of Oct4, Pax6 and Sox 
1 were detected in these cells treated by ATC (+MB+US) 
(Figure S3, Supporting Information), suggesting that ATC-
mediated upregulation of neuroecdoderm markers (Figure 2) 
depended on mechanobiology pathways involving activation 
of focal adhesion components, actomyosin contractility (with 
myosin II), and Rho/ROCK signaling.
Following the observation of upregulated Pax6 and Sox1 
expression after ATC treatment (for 30 min) and culture in 
NIM for 6 h, we conducted experiments to further examined 
the cells 48 h after ATC application. Excitingly, ATC treatment 
followed by 48-h culture in NIM induced the formation of 
neural rosettes, where significantly upregulated Pax6 and Sox1 
expression was observed and accompanied by significant loss 
of Oct4 expression (Figure 3A,B). Compared to the results at 
6 h post ATC treatment (Figure 2), almost all of the ATC-treated 
cells exhibited decreased Oct4, as well as upregulated Pax6 and 
Sox1 after 48-h culture in NIM (Figure 3C,D). In contrast, no 
changes in Oct4, Pax6, or Sox1 were detected in cells in the 
control groups −MB−US+NIM (Figure 3A–D), −MB+US+NIM 
(Figure S4, Supporting Information), and +MB−US+NIM 
(Figure S4, Supporting Information). On the other hand, in 
the absence of NIM, ATC treatment alone (+MB+US−NIM) 
decreased Oct4 expression, similarly as before (Figure 2E,F),[22] 
but produced neither change in Pax6 and Sox1 expression nor 
neural rossette formation (Figure 3E–H). Results of statistical 
analysis of the four groups with NIM (Figure 3C; Figure S4C, 
Supporting Information) and two groups without NIM 
(Figure 3G) shown in Table S2, Supporting Information, indi-
cate that ATC induced statistically significant changes in Pax6 
and Sox1 in the presence of NIM compared to controls without 
ATC. In addition, cells treated by ATC exhibited statistically 
significant decrease in Oct4 after 48 h without NIM (Table S2, 
Supporting Information; Figure 3A,B), but no changes in Pax6 
and Sox1 were detected in the cells treated by ATC without 
NIM at 48 h.
These results suggest that combined action of the integrin-
targeted cyclic forces/strains mediated by ATC and chemical 
factors in NIM facilitated neural induction of hESCs, signified 
by upregulation of neural-ectodermal markers and formation of 
neural rosettes after 48 h. Such rapid changes facilitated by ATC 
application is in great contrast with the typical time frame of 7 – 
10 days needed for neural rosette formation when only soluble 
factors are used.[30] The accelerated neural induction of hESCs 
by a short duration of ATC application suggests a unique mech-
anism of mechanotransduction in hESCs that involves integrin-
targeted cyclic force/strain as a potent mechanical signal.
To further study the role of ATC in the observed rapid neural 
induction of hESCs, we performed reverse transcription quan-
titative real-time PCR (RT-qPCR) to examine the temporal pro-
files of expression of pluripotency (Nanog, Oct4, and Sox2) and 
neuro-ectodermal related genes (Pax6, Sox1, Nestin, Ap2a1, 
Ap2a2, and βIII-Tubulin) in cells at 6, 24, and 48 h after 30 min 
ATC treatment.
Our results show that without the impact of ATC (−MB−
US+NIM, −MB+US+NIM, +MB−US+NIM), cells did not exhibit 
changes in Nanog and Sox2 after culture in NIM (Figure 4A). 
In contrast, application of ATC followed by culture in NIM 
(+MB+US+NIM) induced changes in Nanog (at 6, 24, and 48 h) 
and Sox2 (at 24 and 48 h) (Figure 4A), suggesting disruption 
of the pluripotency transcription factor circuitry in these cells. 
Our RT-qPCR analysis did not reveal a significant decrease in 
Oct4 in cells treated by ATC and NIM, in contrast to our find-
ings from ICC analysis (Figures 2 and 3). In addition, while 
decreased Nanog and increased Nestins were mostly reported in 
literature regarding neural differentiation of hESCs by soluble 
factors alone, the mechanisms of ATC induced neural differen-
tiation of hESCs are unknown for us to pinpoint the causes of 
our observations.
Application of ATC followed by culture in NIM also resulted 
in notable changes in neuro-ectodermal gene expression 
(Figure 4B). Increased Sox1 was seen (at 6, 24, and 48 h) along 
with increased Pax6 (at 24 and 48 h), an observation generally 
in-line with our ICC results which show increases of both Pax6 
and Sox1 at 6 h (Figure 2). Nestin and βIII-Tubulin (Tubbb3) 
appear to decrease in cells treated by ATC (+MB+US+NIM), 
but no significant changes in neural crest (NC) markers Ap2a1 
and Ap2a2 were observed in cells treated by ATC and NIM 
(Figure 4B). Results of statistical analysis the four groups with 
NIM (Figure 4) are shown in Table S3, Supporting Information.
The differences between the RT-qPCR results and ICC results 
in this study could be attributed to factors associated with the 
specific mechanisms of the two techniques. RT-qPCR exam-
ines mRNA while ICC detects protein. Post-transcriptional and 
Adv. Biosys. 2019, 3, 1900064
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Figure 3. Application of ATC (30 min) followed by 48 h culture in NIM promotes neural rosettes formation. A,B) Representative ICC images showing 
that ATC treatment followed 48h culture in NIM upregulated PAX6 and SOX1 but decreased OCT4, along with formation of neural rosettes and 
membrane translocation of β-catenin. Scale bar 50 µm. C) Histograms of OCT4, PAX6, and SOX1 fluorescence intensity for cells in +MB+US+NIM 
and −MB−US+NIM group. A total of 4413 cells (+MB+US+NIM) and 1708 cells (−MB−US+NIM) from six independent experiments were analyzed 
for OCT4. A total of 2244 cells (+MB+US+NIM) and 942 cells (−MB−US+NIM) from three independent experiments were analyzed for PAX6. A total 
of 2169 cells (+MB+US+NIM) and 766 cells (−MB−US+NIM) from three independent experiments were analyzed for SOX1. D) Scatter plots of PAX6 
versus OCT4, and SOX1 versus OCT4 for +MB+US+NIM and −MB−US−NIM group. E,F) Representative ICC images showing that ATC (+MB+US) 
treatment in the absence of NIM resulted in decrease of OCT4 in a small number of hESCs. No PAX6 nor SOX1 upregulation was observed for 
+MB+US−NIM or −MB−US−NIM group. Scale bar 50 µm. G) Histograms of OCT4, PAX6, and SOX1 fluorescence intensity for +MB+US−NIM and 
−MB−US−NIM group at 48 h. A total number of 3928 cells (+MB+US−NIM) and 6024 cells (−MB−US−NIM) from six independent experiments were 
analyzed for OCT4. A total of 2738 cells (+MB+US−NIM) and 4718 cells (−MB−US−NIM) from three independent experiments were analyzed for PAX6. 
A total of 1190 cells (+MB+US−NIM) and 1306 cells (−MB−US−NIM) from three independent experiments were analyzed for SOX1. H) Scatter plots 
of PAX6 versus OCT4, and SOX1 versus OCT4 for +MB+US−NIM and −MB−US−NIM group.
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posttranslational regulation steps during the complex pathways 
from gene to protein may lead to a lack of correlation of tran-
scription and translation outcomes,[31] which could explain the 
observed discrepancy between RT-qPCR (mRNA) and ICC (pro-
tein) results in our study. In addition, in RT-qPCR, all cells were 
collected from an experiment for analysis, while ICC examined 
individual cells and thus could clearly detect heterogeneity of 
response in the cell population. As shown in Figure 2, not all 
cells exhibited changes in protein expression for Oct4, Pax6, 
and Sox1 at 6 h after ATC application. The heterogeneity of 
this cell response could be due to intrinsic cell heterogeneity 
such that some cells respond to ATC stimulation earlier than 
Adv. Biosys. 2019, 3, 1900064
Figure 4. Relative transcript levels of pluripotency and neural genes from RT-qPCR analysis of cells in in all groups (−MB−US, −MB+US, +MB−US, 
+MB+US) after ATC treatment followed by 6, 24, and 48 h culture in neural induction medium (NIM). A) Relative transcript levels of pluripotency 
genes (Nanog, Oct4, and Sox2) B) Relative transcript levels neuroectoderm transcription factors (Pax6, Sox1, Nestin, Tubb3, AP2a1, and Ap2a2). All 
data were normalized against GAPDH and the cells without microbubbles (MBs), ultrasound (US), and NIM (−MB−US−NIM), and plotted as the 
mean, with n = 3 independent experiments. One-way ANOVA-TUKEY multiple comparison test was performed for all groups in each panel. *: p < 0.05; 
**: p < 0.01; ***: p < 0.001; ****: p < 0.0001.
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others. In addition, MBs attachment was not uniform for all 
cells (Figure 1A), and this may result in some inhomogeneity 
in the effect of ATC on individual cells. Thus when all cells 
were collected for RT-qPCR analysis, which measured the com-
bined response of all cells present, response of the affected cells 
may go un-detected against the background of nonresponsive 
cells in the population, particularly at the early time point of 6 h 
after ATC in our experiments.
Since not every cell was attached with MBs, it is reason-
able to expect that the number of MBs/cell could be impor-
tant in ATC induced neural differentiation with the ultimate 
goal of generating functional neurons with high purity and 
yield. However, our previous study has revealed that ATC gen-
erated a global and homogenous responses in all hESCs in a 
colony even though only a subpopulation of cells were attached 
with MBs, suggesting the contribution of cell-cell contacts/
communication.[22] In the current study, while not all cells 
exhibited changes in protein expression for Oct4, Pax6, and 
Sox1 at the early time point of 6 h after ATC (Figure 2), eventu-
ally almost all cells exhibited these changes at 48 h (Figure 3), 
suggesting again the role of cell-cell communication in cellular 
responses to ATC stimulation.
Taken together, these data demonstrate that ATC-mediated 
cyclic strain alters transcriptional activities in hESCs and ini-
tiates upregulation of Pax6 and Sox1 expression in the pres-
ence of biochemical cues. The results from both RT-qPCR and 
ICC analyses are generally consistent, especially when neural 
rosettes were formed and significantly increased Pax6 and 
Sox1 were detected 48 h after ATC application (Figure 3 and 
Figure 4B).
Compared to the results of neural rosettes induced by chem-
ical factors alone, our results reveal differences in Pax6 and 
Sox1 expression, which may underscore the unique mecha-
nism for the accelerated neural induction of hESCs by the 
combined action of ATC-medicated mechanical forces and 
soluble factors. For example, in the presence of growth factors 
and inhibitors (without mechanical forces), Pax6, but not Sox1, 
was expressed in neural rosettes at day 10,[30] which was also 
a much longer time duration than the 48 h observed in our 
study. Another study showed that treatment with chemically 
defined medium supplemented with noggin generated Pax6+/
Sox1- neural rosettes, while Pax6+/Sox1+ rosettes only formed 
after fibroblast growth factors such as FGF2 and FGF8 were 
supplemented.[32]
Differentiation of hESCs into a specific cell lineage is a 
complex process involving multiple stages. Detailed under-
standing of this elaborate process may provide critical insights 
into early development and for cell therapies that require effi-
cient methods for directed differentiation of hESCs in vitro. 
Leveraging the intrinsic mechanosensitivity of hESCs and the 
unique capability of ATC for applying integrin-targeted cyclic 
force/strain to hESCs, this study demonstrated that combined 
action of ATC and NIM accelerated upregulation of neuroecdo-
derm markers and formation of neural rosettes. While our 
ultimate goal is to develop ATC for facilitating hESC neural dif-
ferentiation to obtain fully functional MNs with high purity and 
yield, our objective in this study was to demonstrate the utility 
of ATC-mediated integrin-targeted cyclic force/strain in mecha-
nobiology of hESCs. Results from this study not only highlight 
the unique role of ATC in initiating hESC neural differentia-
tion, but also reveal an integrated mechanism requiring both 
dynamic mechanical forces and chemical factors for acceler-
ating neural differentiation of hESCs.
In this study, ATC was applied for 30 min to exert cyclic 
forces/strains to hESCs via the MB-integrin-CSK linkage by 
using ultrasound pulses with a defined pulse duration, pulse 
repetition frequency, and acoustic pressures. The ultrasound 
parameters used in this study need not be the only choices 
and may be optimized to further improve the outcome of 
neural induction of hESCs in future studies. Besides acoustic 
pressure and pulse duration, MB displacement could also be 
influenced by interactions among bubbles in close range of 
each other, due to the secondary acoustic radiation force as 
shown before.[18] Thus, the number of MBs per cell will be 
another factor to consider even under the same ultrasound 
parameters.
Our measurements in this study show that the integrin-
bound MBs were displaced without detachment, suggesting 
the role of the MB displacement in the decrease of Oct4 in the 
hESCs (Figure 1E,F) that could be related to the distortion/
strain applied to the FA-CSK linkage of the cells subjected to 
ATC treatment. Although the exact mechanism of ATC-induced 
hESC differentiation remains to be shown, it is possible that 
ATC-induced distortion/strain to the FA-CSK linkage may 
expose protein binding sites responsible for mechanotransduc-
tion in hESCs.[24]
We employed RT-qPCR and ICC in this study to evaluate the 
dynamic changes in mRNA expression and protein expression 
during neural differentiation of hESCs induced by ATC and 
NIM. RT-qPCR gives mRNA abundance but may not be directly 
indicative of protein abundance. On the other hand, ICC offers 
high spatial resolution and provides information regarding 
protein localization within each cell and co-expression with 
other proteins. ICC also identifies affected and unaffected 
cells, allowing assessment of inhomogeneity in cell responses. 
While beyond the scope of current study, future investigations 
are needed to evaluate correlation between mRNA expression 
and protein expression in ATC-induced accelerated neural dif-
ferentiation of hESCs, and to determine the dynamic changes 
in expression of pluripotent genes and how they are related to 
the neural genes in the transition from a pluripotent cell to a 
neural–specific cell type.
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